http://www.zibb.com/healthcare/theme/cq/ACADIA+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 06 May 2009 12:00:00 GMTWed, 06 May 2009 12:00:00 GMT608831http://www.zibb.com/healthcare/theme/cq/ACADIA+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://finance.yahoo.com/news/ACADIA-Pharmaceuticals-and-bw-15147329.html?.v=1SAN DIEGO & TORONTO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD - News) and Biovail Corporation (NYSE:BVF - News) (TSX:BVF -http://finance.yahoo.com/news/ACADIA-Pharmaceuticals-and-bw-15147329.html?.v=1ACADIA Pharmaceuticals IncorporatedWed, 06 May 2009 12:00:00 GMThttp://seekingalpha.com/article/104199-earnings-preview-king-pharmaceuticals?source=yahooKing Pharmaceuticals (KG) is expected to report Q3 earnings before market open Thursday, November 6, with a conference call scheduled for 11:00 am ET.http://seekingalpha.com/article/104199-earnings-preview-king-pharmaceuticals?source=yahooACADIA Pharmaceuticals IncorporatedWed, 05 Nov 2008 18:43:32 GMThttp://www.biospace.com/news_story.aspx?StoryID=105701&full=1SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD - News), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for thehttp://www.biospace.com/news_story.aspx?StoryID=105701&full=1ACADIA Pharmaceuticals IncorporatedTue, 05 Aug 2008 12:00:00 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=320686S. financial markets close. ACADIA's management will host a conference call and webcast on Monday, March 9, 2009, at 5:00 p.m. Eastern Time to discuss ACADIA?s financial results and development programs.http://www.pharmacychoice.com/News/article.cfm?Article_ID=320686ACADIA Pharmaceuticals Incorporatedhttp://www.biospace.com/news_story.aspx?StoryID=100274&full=1SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD - News) today announced results from its Phase IIb trial with ACP-104 for the treatment of schizophrenia. The study did not meet its primary endpoint of antipsychotic efficacy or any of the secondary endpoints. Neither dose ofhttp://www.biospace.com/news_story.aspx?StoryID=100274&full=1ACADIA Pharmaceuticals IncorporatedMon, 16 Jun 2008 12:00:00 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=323324A live webcast of ACADIA?s presentation will be accessible on the company?s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through March 25, 2009.http://www.pharmacychoice.com/News/article.cfm?Article_ID=323324ACADIA Pharmaceuticals Incorporated